Illumina MiSeq – Benchtop NGS Sequencing System

currently with a customer who doesn't need it, Illustrative photo

MiSeq front
  • Ref No.: MiSeq
  • Availability: Just one piece
Contact us at info@lifem.eu

The Illumina MiSeq is a compact benchtop next-generation sequencing (NGS) system based on Sequencing by Synthesis (SBS) technology. It is designed for high-quality sequencing of DNA and applications involving nucleic acid sequencing.

Main features

  • Manufacturer: Illumina
  • Model: MiSeq System
  • Type: Benchtop NGS sequencer
  • Technology: Sequencing by Synthesis (SBS)
  • Supports single-end and paired-end sequencing
  • Maximum read length of up to 2 × 300 bp
  • Maximum output of up to 15 Gb per run using the MiSeq Reagent Kit v3, 600-cycle
  • Up to 25 million single-end reads or up to 50 million paired-end reads, depending on the reagent kit and run conditions
  • Integrated workflow including cluster generation, sequencing, base calling and data processing
  • Single flow cell per sequencing run
  • Different reagent kits allow sequencing output and read length to be adapted to the application
  • Suitable for applications including:
    • targeted gene sequencing,
    • amplicon sequencing,
    • 16S metagenomic analysis,
    • microbial genome sequencing,
    • small genome sequencing,
    • genetic variant analysis,
    • other research and laboratory applications.

Technical specifications

  • Maximum read length: 2 × 300 bp
  • Output: approximately 540 Mb to 15 Gb, depending on the reagent kit
  • Maximum reads: up to 25 M single-end reads / 50 M paired-end reads
  • Run time: approximately 4–56 hours depending on the run configuration
  • Dimensions (W × D × H): approximately 68.6 × 56.5 × 52.3 cm

Instrument condition

 

  • Purchase date: 23 June 2021
  • In operation until: 03/2026
  • Operating history: trouble-free operation according to the available information
  • Current condition: fully functional
  • Suitable for further laboratory use, research, sequencing and NGS applications.
Show MoreLess